[Immunotherapy of colorectal cancers].
Bécouarn
Y
Y
Service d'Oncologie Digestive et de Gastroentérologie, Institut Bergonié, Bordeaux.
Seitz
J F
JF
Perrier
H
H
Rouhier
M L
ML
Giovannini
M
M
Brunet
R
R
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic; D001500:BCG Vaccine / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D016207:Cytokines / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D007978:Levamisole / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D000964:Antimetabolites, Antineoplastic; D001500:BCG Vaccine; D016207:Cytokines; D007978:Levamisole; D005472:Fluorouracil
Immunothérapie des cancers colo-rectaux.